Literature DB >> 24257628

Efficient CRISPR/Cas9 genome editing with low off-target effects in zebrafish.

Alexander Hruscha1, Peter Krawitz, Alexandra Rechenberg, Verena Heinrich, Jochen Hecht, Christian Haass, Bettina Schmid.   

Abstract

Gene modifications in animal models have been greatly facilitated through the application of targeted genome editing tools. The prokaryotic CRISPR/Cas9 type II genome editing system has recently been applied in cell lines and vertebrates. However, we still have very limited information about the efficiency of mutagenesis, germline transmission rates and off-target effects in genomes of model organisms. We now demonstrate that CRISPR/Cas9 mutagenesis in zebrafish is highly efficient, reaching up to 86.0%, and is heritable. The efficiency of the CRISPR/Cas9 system further facilitated the targeted knock-in of a protein tag provided by a donor oligonucleotide with knock-in efficiencies of 3.5-15.6%. Mutation rates at potential off-target sites are only 1.1-2.5%, demonstrating the specificity of the CRISPR/Cas9 system. The ease and efficiency of the CRISPR/Cas9 system with limited off-target effects make it a powerful genome engineering tool for in vivo studies.

Entities:  

Keywords:  C9orf72; CRISPR/Cas9; Genome editing; Knock in; Off-target; Tardbp; Zebrafish

Mesh:

Substances:

Year:  2013        PMID: 24257628     DOI: 10.1242/dev.099085

Source DB:  PubMed          Journal:  Development        ISSN: 0950-1991            Impact factor:   6.868


  186 in total

1.  The fish embryo test (FET): origin, applications, and future.

Authors:  Thomas Braunbeck; Britta Kais; Eva Lammer; Jens Otte; Katharina Schneider; Daniel Stengel; Ruben Strecker
Journal:  Environ Sci Pollut Res Int       Date:  2014-11-15       Impact factor: 4.223

2.  Dynamic visualization of transcription and RNA subcellular localization in zebrafish.

Authors:  Philip D Campbell; Jeffrey A Chao; Robert H Singer; Florence L Marlow
Journal:  Development       Date:  2015-03-10       Impact factor: 6.868

3.  Target specificity of the CRISPR-Cas9 system.

Authors:  Xuebing Wu; Andrea J Kriz; Phillip A Sharp
Journal:  Quant Biol       Date:  2014-06

4.  Tracking and transforming neocortical progenitors by CRISPR/Cas9 gene targeting and piggyBac transposase lineage labeling.

Authors:  Fuyi Chen; Joel Rosiene; Alicia Che; Albert Becker; Joseph LoTurco
Journal:  Development       Date:  2015-09-23       Impact factor: 6.868

5.  A streamlined CRISPR pipeline to reliably generate zebrafish frameshifting alleles.

Authors:  Jared Coffin Talbot; Sharon L Amacher
Journal:  Zebrafish       Date:  2014-12       Impact factor: 1.985

6.  CRISPR/Cas9-mediated conversion of eGFP- into Gal4-transgenic lines in zebrafish.

Authors:  Thomas O Auer; Karine Duroure; Jean-Paul Concordet; Filippo Del Bene
Journal:  Nat Protoc       Date:  2014-11-13       Impact factor: 13.491

7.  Measuring protein stability in living zebrafish embryos using fluorescence decay after photoconversion (FDAP).

Authors:  Katherine W Rogers; Alexander Blässle; Alexander F Schier; Patrick Müller
Journal:  J Vis Exp       Date:  2015-01-28       Impact factor: 1.355

8.  GIPC proteins negatively modulate Plexind1 signaling during vascular development.

Authors:  Jorge Carretero-Ortega; Zinal Chhangawala; Shane Hunt; Carlos Narvaez; Javier Menéndez-González; Carl M Gay; Tomasz Zygmunt; Xiaochun Li; Jesús Torres-Vázquez
Journal:  Elife       Date:  2019-05-03       Impact factor: 8.140

Review 9.  The new CRISPR-Cas system: RNA-guided genome engineering to efficiently produce any desired genetic alteration in animals.

Authors:  Davide Seruggia; Lluis Montoliu
Journal:  Transgenic Res       Date:  2014-08-06       Impact factor: 2.788

10.  A Quantitative System for Studying Metastasis Using Transparent Zebrafish.

Authors:  Silja Heilmann; Kajan Ratnakumar; Erin Langdon; Emily Kansler; Isabella Kim; Nathaniel R Campbell; Elizabeth Perry; Amy McMahon; Charles Kaufman; Ellen van Rooijen; William Lee; Christine Iacobuzio-Donahue; Richard Hynes; Leonard Zon; Joao Xavier; Richard White
Journal:  Cancer Res       Date:  2015-08-17       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.